Navigation Links
Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Date:10/23/2007

lopment of its key assets to build stockholder value. http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding these preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera's history of operating losses since inception and its need for additional funds to operate its business; the costs, delays and uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process; the risk that clinical trials for Genaera's product candidates, including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine may be delayed or may not be successful; the risk that Genaera may not obtain regulatory approval for its products, whether due to adequacy of the development program, the conduct of the clinical trials, changing regulatory requirements, different methods of evaluating and interpreting data, regulatory interpretations of clinical risk and benefit, or otherwise; Genaera's reliance on its collaborators, in connection with the development and commercializ
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014   Hospira, Inc. (NYSE: ... and infusion technologies, today announced that the company will ... on Wednesday, Jan. 14, 2015, in San Francisco.  ... at 10:30 a.m. Pacific time on Wednesday, Jan. 14, ... through a live audiocast accessible via the Investor Relations ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
(Date:12/19/2014)... , Dec. 18, 2014  Sage Analytics ... generation of equipment for the testing of marijuana ... of the new Luminary™ Profiler, the industry,s first ... measurement in a cost-effective, portable unit. ... specific needs of the cannabis industry, the Luminary™ ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... Aug. 3 Omnicell, Inc ., (Nasdaq: ... system solutions to acute healthcare facilities, today released the new ... The next generation of packaging technology supports bar code medication ... accuracy. Integrated with the latest WorkflowRx software, version 7.0, this ...
... BEIJING , Aug. 3 ... LTUS ) ("Lotus" or the "Company"), ... in the People,s Republic of,China (the "PRC"), ... ingredient ("API") and tablets of R-Bambuterol for use in,clinical ...
Cached Medicine Technology:Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 2Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 3Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 4Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials 2Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials 3
(Date:12/19/2014)... (PRWEB) December 20, 2014 The print ... Home and Business subscription of the Toronto Star, with ... readership of 622,169. The digital component is distributed nationally ... network of top news sites and partner outlets. To ... here . , The publication features an exclusive ...
(Date:12/19/2014)... -- The intestinal bacteria that cause inflammatory bowel disease, ... inherited, researchers report. The findings, published recently in ... efforts to prevent the disease and treat the 1.6 ... added. "The intestinal bacteria, or ,gut microbiome, you ... big impact on your health for the rest of ...
(Date:12/19/2014)... Potentially illness-causing E. coli bacteria were found on nearly ... a new study. Researchers checked cilantro, basil and ... in Los Angeles and Orange counties in California, and ... tested, 24 percent were positive for E. coli. One ... Both types of bacteria can cause sometimes serious ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Dense bunches of bacteria called ... a new study finds. The researchers said these ... colon. The presence of these biofilms may represent an ... way to predict a person,s risk for the disease, the ... stones, these biofilms may coat the mucus layer of cells ...
(Date:12/19/2014)... Older adults who have lost all their teeth have faster ... have at least some of their teeth, a new study ... provide an early warning of increased risk of physical and ... However, the findings don,t prove that tooth loss causes the ... 3,100 participants 60 and older. People with no remaining teeth ...
Breaking Medicine News(10 mins):Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2
... of Public Health has awarded CNN anchor and special ... efforts while reporting on the devastating effects of Hurricane ... with the award at a ceremony at the Bloomberg ... O,Brien has shown the world tragedies of human conflict, ...
... by New Legislation , , ... (UBC) Annette Stemhagen, DrPH, FISPE, and Gerald Faich, MD, ... Summit held in Washington, DC, on October 28 and ... Jane Axelrad, Associate Director for Policy, CDER, FDA; Claudia ...
... group of consumers filed a proposed,nationwide class-action lawsuit earlier ... AG (FRA: BAY), alleging the pharmaceutical giant,skirted FDA requirements ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) , ... that Bayer markets two of its over-the-counter products --,Bayer ...
... Health plans today proposed guaranteed coverage for people with pre-existing ... , , Under the ... market would be required to offer coverage to all applicants ... individuals were required to maintain health insurance. , ...
... How is a Shortage of Primary Care Physicians Affecting the ... the American College of Physicians (ACP) documents the value of ... bibliography based on a literature review of more than 100 ... primary care in providing patients with better outcomes at lower ...
... they can raise long-term health risks, studies say , , ... poor caregiver relationships each increase levels of the stress ... two studies, published in the November/December issue of ... on children in these common situations. , Long-term or ...
Cached Medicine News:Health News:Bloomberg School awards Goodermote Humanitarian Award to Soledad O'Brien 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 3Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 2Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 3Health News:Health Plans Propose Guaranteed Coverage for Pre-Existing Conditions and Individual Coverage Mandate 2Health News:Health Plans Propose Guaranteed Coverage for Pre-Existing Conditions and Individual Coverage Mandate 3Health News:Primary care provides patients with better outcomes at lower cost 2Health News:Child-Care Relationships Tied to Kids' Stress Levels 2Health News:Child-Care Relationships Tied to Kids' Stress Levels 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: